Showing 1,701 - 1,720 results of 152,992 for search '(( a we decrease ) OR ( 5 ((((mean decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.93s Refine Results
  1. 1701
  2. 1702
  3. 1703
  4. 1704
  5. 1705
  6. 1706
  7. 1707

    Tetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent Autophagy by Viviana A. Cavieres (500139)

    Published 2015
    “…We show herein that IDN5706 decreases the levels of ER degradation enhancer, mannosidase alpha-like 1 (EDEM1), a key chaperone related to endoplasmic-reticulum-associated degradation (ERAD). …”
  8. 1708
  9. 1709
  10. 1710
  11. 1711
  12. 1712

    Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis by Yan Sun (22436)

    Published 2020
    “…The number of catheters removed due to infection or suspected infection was not significantly different between the two groups (RR: 0.68; 95% CI:0.22, 2.10; I<sup>2</sup> = 56%; P = 0.50) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231110#pone.0231110.g005" target="_blank">Fig 5</a>). …”
  13. 1713

    Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. by Pranjali Beri (14945400)

    Published 2023
    “…Compounds that appeared to cause toxicity were identified by observing a significant decrease in spheroid counts in the swell readout or a significant decrease in the total nuclear intensity of the MUC5AC ratio readout. …”
  14. 1714
  15. 1715
  16. 1716
  17. 1717
  18. 1718
  19. 1719

    A sample choice question with a warning label. by Yulian Ding (5984591)

    Published 2024
    “…We draw a sample of 1200 participants from five major cities across China to analyze the warning label’s effectiveness in reducing urban consumers’ purchases of SSBs, with a particular emphasis on how an individual’s habit strength affects their reaction to the warning label. …”
  20. 1720

    Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial by Andreas Hartmann (241073)

    Published 2016
    “…We conducted a prospective, randomized double-blind study in 40 Parkinson disease patients at Hoehn & Yahr stages 1.5 to 3 who were either assigned to monthly bee venom injections or equivalent volumes of saline (treatment/placebo group: n = 20/20). …”